Francesca Merchionne
- Molecular Biology
- Oncology top 10%
- Hematology top 5%
- Cancer Research
- Immunology
- Co-authors
- Franco DammaccoDoménico RibattiAngelo VaccaRoberto RiaMonica IurlaroFederico PerosaBeatrice NicoFrancesco Di Raimondo
- Topics
- Lymphoma Diagnosis and Treatment (6 papers)Multiple Myeloma Research and Treatments (5 papers)Angiogenesis and VEGF in Cancer (5 papers)
- Partner nations
- ItalySwitzerlandJapan
In The Last Decade
Francesca Merchionne
21 papers receiving 651 citations
Peers
Comparison fields: 5 of 76
- Molecular Biology 362
- Oncology 251
- Hematology 194
- Cancer Research 125
- Immunology 84
Countries citing papers authored by Francesca Merchionne
This map shows the geographic impact of Francesca Merchionne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Merchionne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Merchionne more than expected).
Fields of papers citing papers by Francesca Merchionne
This network shows the impact of papers produced by Francesca Merchionne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Merchionne. The network helps show where Francesca Merchionne may publish in the future.
Co-authorship network of co-authors of Francesca Merchionne
This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Merchionne. A scholar is included among the top collaborators of Francesca Merchionne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Merchionne. Francesca Merchionne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 22 | |
| 2 | Azacitidine in the front-line treatment of therapy-related myeloid neoplasms: a multicenter case series. | 6 |
| 3 | 41 | |
| 4 | 11 | |
| 5 | 4 | |
| 6 | 26 | |
| 7 | 12 | |
| 8 | 12 | |
| 9 | 11 | |
| 10 | 8 | |
| 11 | 22 | |
| 12 | 37 | |
| 13 | 67 | |
| 14 | 7 | |
| 15 | 65 | |
| 16 | 30 | |
| 17 | 111 | |
| 18 | Alpha(v)beta(3) integrin engagement enhances cell invasiveness in human multiple myeloma. | 72 |
| 19 | 74 | |
| 20 | 31 |
About Francesca Merchionne
Francesca Merchionne is a scholar working on Hematology, Cancer Research and Oncology, having authored 21 papers that have together received 670 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (6 papers), Multiple Myeloma Research and Treatments (5 papers) and Angiogenesis and VEGF in Cancer (5 papers). The work is most often cited by research in Hematology (194 citations), Immunology and Allergy (77 citations) and Oncology (251 citations). Francesca Merchionne has collaborated with scholars based in Italy, Switzerland and Japan. Frequent co-authors include Franco Dammacco, Doménico Ribatti, Angelo Vacca, Roberto Ria, Monica Iurlaro, Federico Perosa, Beatrice Nico, Francesco Di Raimondo, Angelo Vacca and Aldo M. Roccaro. Their work appears in journals such as Blood, The Journal of Immunology and Molecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.